Item 7.01 Regulation FD Disclosure.
On
This information is being furnished pursuant to Item 7.01 of this Report and
shall not be deemed to be "filed" for the purposes of Section 18 of the
Securities and Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section and will not be incorporated by reference into any
registration statement filed by
Please refer to page 2 of the presentation attached hereto as Exhibit 99.1 for a discussion of certain forward-looking statements included therein and the risks and uncertainties related thereto.
Item 9.01 Financial Statements and Exhibits. Exhibit No. DescriptionHalozyme Therapeutics, Inc. corporate update presentation, dated 99.1January 16, 2020 Cover Page Interactive Data File (embedded within the Inline XBRL 104 document )
--------------------------------------------------------------------------------
© Edgar Online, source